What does every parent need to know about group B Strep? What are the three most important things?
Thanks to this discussion, I have learned three things:
1) GBS is common and usually harmless in adults, but it can be life‑threatening for newborns. Around 10–30% of pregnant women carry GBS without symptoms. It is part of the normal gut/vaginal microbiome and usually causes no problems for the mother. But for babies, GBS can cause sepsis, pneumonia, and meningitis, especially in the first week of life.
2) Most early-onset GBS infections can be prevented with antibiotics during labour. If a mother carries GBS, IV antibiotics given at least 4 hours before birth reduce the risk of early-onset disease by about 80%. This is why knowing your GBS status and receiving timely treatment during labour is important. Howevr, in many countries (eg UK), universal screening is not done - only 'high-risk' mothers are screened. (I haven't yet learned whether this high-risk approach is adequate.)
3) Parents must know the warning signs of GBS infection in babies up to 3 months old. Symptoms can appear at birth or weeks later. Seek urgent medical care if a baby shows:
poor feeding or vomiting
fever or very low temperature
lethargy, irritability, or unusual sleepiness
breathing problems (grunting, fast breathing, working hard to breathe)
pale, blue, or blotchy skin
bulging soft spot (late-onset meningitis)
*Every baby* must be monitored closely in the neonatal period. Clinicians should start empirical antibiotics before test results are available, because newborn infections can progress very quickly. Penicillin or ampicillin is typically used first, often in combination with gentamicin.
Group B Strep International provides a wide range of leaflets: https://www.groupbstrepinternational.org
Best wishes, Neil
CHIFA profile: Neil Pakenham-Walsh is coordinator of HIFA (Healthcare Information For All), a global health community that brings all stakeholders together around the shared goal of universal access to reliable healthcare information. HIFA has 20,000 members in 180 countries, interacting in four languages and representing all parts of the global evidence ecosystem. HIFA is administered by Global Healthcare Information Network, a UK-based nonprofit in official relations with the World Health Organization. Email: neil@hifa.org